Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathrin Brockmann

Showing results (11-20 of 163) with videos related to

Pageof 17
Sort By:
Archives of Neurology|July 13, 2011
Serum insulinlike growth factor 1 as possible marker for risk and early diagnosis of Parkinson diseaseJana Godau, Katharina Knauel, Karin Weber, et al.
Frontiers in Neurology|January 9, 2019
Dermal Phospho-Alpha-Synuclein Deposition in Patients With Parkinson's Disease and Mutation of the Glucocerebrosidase GeneKathrin Doppler, Kathrin Brockmann, Annahita Sedghi, et al.
Journal of Neurology|May 9, 2018
Serum neurofilament light is increased in multiple system atrophy of cerebellar type and in repeat-expansion spinocerebellar ataxias: a pilot studyCarlo Wilke, Friedemann Bender, Stefanie N Hayer, et al.
Plos One|February 12, 2011
CAG repeats determine brain atrophy in spinocerebellar ataxia 17: a VBM studyKathrin Reetz, Alexandra Kleiman, Christine Klein, et al.
Brain, Behavior, and Immunity|January 13, 2022
Changes in CD163+, CD11b+, and CCR2+ peripheral monocytes relate to Parkinson's disease and cognitionSara Konstantin Nissen, Kristine Farmen, Mikkel Carstensen, et al.
Parkinsonism & Related Disorders|October 18, 2015
Neurodegenerative CSF markers in genetic and sporadic PD: Classification and prediction in a longitudinal studyKathrin Brockmann, Claudia Schulte, Christian Deuschle, et al.
Acta Neuropathologica Communications|October 9, 2023
Kinetic parameters of alpha-synuclein seed amplification assay correlate with cognitive impairment in patients with Lewy body disordersStefan Bräuer, Marcello Rossi, Johann Sajapin, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 3, 2014
GBA-associated Parkinson's disease: reduced survival and more rapid progression in a prospective longitudinal studyKathrin Brockmann, Karin Srulijes, Sylvia Pflederer, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|May 31, 2022
GBA-associated PD: chances and obstacles for targeted treatment strategiesGünter Höglinger, Claudia Schulte, Wolfgang H Jost, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 16, 2013
SNCA: major genetic modifier of age at onset of Parkinson's diseaseKathrin Brockmann, Claudia Schulte, Ann-Kathrin Hauser, et al.
Pageof 17

Showing results (11-20 of 163) with videos related to

Sort By:
Pageof 17
Archives of Neurology|July 13, 2011
Serum insulinlike growth factor 1 as possible marker for risk and early diagnosis of Parkinson diseaseJana Godau, Katharina Knauel, Karin Weber, et al.
Frontiers in Neurology|January 9, 2019
Dermal Phospho-Alpha-Synuclein Deposition in Patients With Parkinson's Disease and Mutation of the Glucocerebrosidase GeneKathrin Doppler, Kathrin Brockmann, Annahita Sedghi, et al.
Journal of Neurology|May 9, 2018
Serum neurofilament light is increased in multiple system atrophy of cerebellar type and in repeat-expansion spinocerebellar ataxias: a pilot studyCarlo Wilke, Friedemann Bender, Stefanie N Hayer, et al.
Plos One|February 12, 2011
CAG repeats determine brain atrophy in spinocerebellar ataxia 17: a VBM studyKathrin Reetz, Alexandra Kleiman, Christine Klein, et al.
Brain, Behavior, and Immunity|January 13, 2022
Changes in CD163+, CD11b+, and CCR2+ peripheral monocytes relate to Parkinson's disease and cognitionSara Konstantin Nissen, Kristine Farmen, Mikkel Carstensen, et al.
Parkinsonism & Related Disorders|October 18, 2015
Neurodegenerative CSF markers in genetic and sporadic PD: Classification and prediction in a longitudinal studyKathrin Brockmann, Claudia Schulte, Christian Deuschle, et al.
Acta Neuropathologica Communications|October 9, 2023
Kinetic parameters of alpha-synuclein seed amplification assay correlate with cognitive impairment in patients with Lewy body disordersStefan Bräuer, Marcello Rossi, Johann Sajapin, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 3, 2014
GBA-associated Parkinson's disease: reduced survival and more rapid progression in a prospective longitudinal studyKathrin Brockmann, Karin Srulijes, Sylvia Pflederer, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|May 31, 2022
GBA-associated PD: chances and obstacles for targeted treatment strategiesGünter Höglinger, Claudia Schulte, Wolfgang H Jost, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 16, 2013
SNCA: major genetic modifier of age at onset of Parkinson's diseaseKathrin Brockmann, Claudia Schulte, Ann-Kathrin Hauser, et al.
Pageof 17